Dr Reddys Laboratories (RDY) Enterprise Value Growth (5y) (2014 - 2026)
Dr Reddys Laboratories (RDY) Enterprise Value Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.48% |
| Mar 31, 2025 | 12.09% |
| Mar 31, 2024 | -18.65% |
| Jun 30, 2023 | -25.30% |
| Mar 31, 2023 | -28.83% |
| Jun 30, 2022 | -16.74% |
| Mar 31, 2022 | -22.59% |
| Dec 31, 2020 | 29.69% |
| Sep 30, 2020 | -16.21% |
| Mar 31, 2020 | -52.75% |
| Dec 31, 2019 | 95.85% |
| Sep 30, 2019 | 14.87% |
| Dec 31, 2018 | 20.17% |
| Mar 31, 2018 | 10.02% |
| Dec 31, 2017 | -660.08% |
| Sep 30, 2017 | -613.14% |
| Mar 17, 2017 | 24.64% |
| Dec 31, 2016 | -570.53% |
| Jun 16, 2016 | -15.53% |
| Dec 31, 2015 | -18.09% |